ArticleFrontiers in immunology2022

Identification of m6A modification patterns and development of m6A-hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer.

Xi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.